Industry & Regulatory Bodies
What’s in store for LPO in 2010?
What does 2010 have in store for the legal process outsourcing industry? From rural outsourcing to technology and 'greening', the IAOP's Jagdish Dalal outlines his predictions ...  »
Searching for clarity
The different approaches to class action suits taken by US federal and some state courts have led to great uncertainty in the law. Sean P Costello and Brooke Werner McEckron assess the implications...  »
Law and economics
Changes in domestic and international transfer pricing law have placed a greater emphasis on economic analysis and legal expertise, explain Danny Beeton, Murray Clayson and Justin Watts of Freshfields....  »
Keeping ahead of the competition: Change management
‘Change management’ has become the latest buzz phrase, as legal heads in both companies and private practice firms struggle to reshape their offerings in order to keep nimble in the current climat....  »
Damage control
Competition law is coming under an increasing amount of scrutiny in Europe and the US. Dr Volker Soyez summarises the latest proposal from the European Commission...  »
Litigation: is there an alternative?
Companies should investigate options for dispute resolution, particularly in the intellectual property arena, say Ralli’s Steve Kuncewicz and David Potts...  »
A new arbitration bill for Scotland
In comparison to court-based resolutions, arbitration can be a cost-effective and speedy process, says Craig Turnbull of Macroberts LLP...  »
The IP guide to: Software patents
A recent decision by the UK Court of Appeal seemed to suggest that initial blocks to software patentability could be relaxed. But the outcome is still not clear. By Kenneth Mullen...  »
‘Women are vital to the survival of the legal industry’
The legal industry was battered by the recession. As we seek to regroup and rebuild, writes Fiona Fitzgerald, it’s time to focus on our most under-valued and untapped resource: women...  »
Pharma in European Commission probe
The European Commission opened a pharmaceutical sector inquiry in January 2008 following concerns that pharmaceutical companies were using the patent system in a market-distorting and unjustified way.....  »